Trial intelligence / Profile preview

Tranexamic acid for reducing intraoperative blood loss during craniotomy for brain tumor excision

IRCT2016122631573N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in brain neoplasm, sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Intraoperative blood loss. Started Jul 2016; status: completed.

02

Drugs

tranexamic acid
03

Conditions

brain neoplasm

Beyond the preview

Go deeper on IRCT2016122631573N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016122631573N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call